Ovarian Cancer Flashcards
Ovarian cancer Ix
TVUSS Tumour markers (CA125) RMI CT+/-MRI Aspiration of ascites USS/CT needle biopsy
What does TVUSS tell you about ovarian cancers?
Size Consistency Solid elements? Bilaterality Ascites? Extraovarian Dx (peritoneal/omental deposits)
Raised CA125?
(80% of epithelial) Ovarian cancers
Pregnancy
Endometriosis
Alcoholic liver dx
RMI
Risk of malignant index Calculated from: - menopausal status - pelvic USS - CA125 >250 high, <25 low
CT/MRI in Ovarian cancer
Indicated in any suspicious pelvic pathology
CT good for staging
MRI determines operability
Surgical Mx of Ovarian Cancer
Stage Dx and remove all visible tumour TAH+BSO + omentectomy Ascites/peritoneal washings sampled ?Further debulking (bowel, peritoneal stripping) LN rescetion important
Most important prognostic factor in ovarian cancer
No residual disease following laparotomy
If unsuitable for ovarian cancer surgery
Chemotherapy w/second look laparotomy to see extent of residual disease
Summary of Mx of ovarian cancer
Surgery w/Pt based chemo
Aim: <1cm residual macroscopic tissue
Ovarian tumour deposits amenable to resection?
Bowel, spleen, peritoneum
Ovarian tumour deposits not amenable to resection?
porta hepatis, bowel mesentary
Supraradical ovarian cancer surgery
BSO+TAH+omentectomy and lympheadenectomy + removal of all visible disease
indicated in prev. fit women w/disseminated dx if complete cytoreduction possible
a/w perioperative mort/morb.
Alternative to supraradical surgery
3 cycles of neoadjuvant chemo followed by debulking is not inferioir and a/w less morbidity
Chemotherapy in ovarian cancer
Can be primary treatment, adjunct or for relapse
1st line: Pt agent w/paclitaxel
OP 3wks apart 6 cycles
Platinum compounds in ovarian cancer
Most effective Cross linkage of DNA strands Carboplatin main compound (less nephrotox. and nausea and cisplatin) Dose of carboplatin calculated using GFR